Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chronic Pain × Donepezil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 4 Medulloblastoma 3 Choroid Plexus Neoplasms 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Pinealoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Meningioma 2 Gliosarcoma 2 Glioma, Subependymal 2 Glioma 2 Glioblastoma 2 Fatigue 2 Ependymoma 2 Depression 2 Craniopharyngioma 2 Cognitive Dysfunction 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Memory Disorders 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Familial ependymoma 1

Interventions

Morphine 7 Surveys and Questionnaires 6 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Control Groups 2 Bupivacaine 2 Acetaminophen 2 ziconotide 1 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Telemedicine 1 Tea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05254639 2024-04-05

DONEPEZOX

University Hospital, Clermont-Ferrand

Phase 2 Completed

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡